In the sub-analysis to evaluate the sensitivity and specificity of HE4 compared with CA125 as a biomarker to discriminate between endometriosis and ovarian cancer, 114 patients were diagnosed with epithelial ovarian cancer and 104 patients were diagnosed with endometriosis. Here, WFDC2 is linked to ovarian carcinoma.